Autologous Low Density Lipoprotein Enhances Platelet Aggregation in Whole Blood, as Measured by In Vitro Filtragometry
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Platelets
- Vol. 4 (1) , 11-15
- https://doi.org/10.3109/09537109309013190
Abstract
The influence of low density lipoprotein (LDL) on platelet aggregability was studied using filtragometry and conventional Born aggregometry in vitro. Three different concentrations of autologous LDL, obtained from 9 healthy male volunteers, were incubated for 20 min, at 37°C, with whole blood anticoagulated with low molecular weight heparin (filtragometry) or citrated platelet-rich plasma (PRP; Born aggregometry). The LDL-cholesterol concentration was increased from 1.7 ± 0.2 mmol/1 to 2.4 ± 0.2, 3.5 ± 0.3 and 5.3 ± 0.5 mmol/l, respectively. Adenosine diphospate (ADP)-induced platelet aggregation in whole blood was enhanced in a dose dependent manner by LDL, as assessed by filtragometry (ADP cone, range 0.1-0.3 μM). Platelet aggregability in PRP (Born) was not affected by LDL at the ED50 for ADP-induced platelet aggregation (i.e. 1-4 μM ADP). The marked platelet activation caused by the high ADP concentrations used with conventional Born aggregometry may have masked a modest LDL-induced platelet activation as a slight increase in spontaneous platelet aggregation was observed in PRP at the intermediate LDL-concentration. The present findings indicate that low concentrations of LDL stimulate platelet aggregability in the physiological whole blood milieu. This adverse effect of LDL-cholesterol may be of clinical importance in patients with hypercholesterolaemia.Keywords
This publication has 26 references indexed in Scilit:
- Influence of platelet size on outcome after myocardial infarctionThe Lancet, 1991
- Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometryClinical Science, 1991
- Platelet aggregability in humans: contrasting in vivo and in vitro findings during sympatho‐adrenal activation and relationship to serum lipidsEuropean Journal of Clinical Investigation, 1990
- Platelet Hyperreactivity and Prognosis in Survivors of Myocardial InfarctionNew England Journal of Medicine, 1990
- Comparison of the platelet pro‐aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222)British Journal of Haematology, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Increased platelet sensitivity and thromboxane B2 formation in type‐II hyperlipoproteinaemic patientsEuropean Journal of Clinical Investigation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Lipoproteins, Cardiovascular Disease, and DeathArchives of internal medicine (1960), 1981
- Platelet Function in HyperlipoproteinemiaNew England Journal of Medicine, 1974